$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

$ssy Overview Financials Valuation SEC Filings Company Website

2012 Q4 Form 10-Q Financial Statement

#000119312513060336 Filed on February 14, 2013

Income Statement

Concept	2012 Q4	2012 Q2	2011 Q4
Revenue	$30.39M	$26.63M	$31.40M
YoY Change	-3.24%	4061.41%	-22.54%
Cost Of Revenue	$1.896M	$4.910M	$1.858M
YoY Change	2.05%	14.19%	-77.99%
Gross Profit	$28.49M	$21.72M	$29.54M
YoY Change	-3.57%	-693.44%	-7.97%
Gross Profit Margin	93.76%	81.55%	94.08%
Selling, General & Admin	$18.35M	$17.22M	$17.74M
YoY Change	3.44%	-777.95%	-31.11%
% of Gross Profit	64.41%	79.28%	60.05%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$989.0K	$1.020M	$1.120M
YoY Change	-11.7%	-3.77%	-21.13%
% of Gross Profit	3.47%	4.7%	3.79%
Operating Expenses	$22.29M	$15.95M	$22.27M
YoY Change	0.09%	26483.33%	-30.23%
Operating Profit	-$974.0K	$5.770M	-$1.059M
YoY Change	-8.03%	-255.11%	-688.33%
Interest Expense	$647.0K	-$980.0K	$1.031M
YoY Change	-37.25%	-44.0%	-131.92%
% of Operating Profit		-16.98%
Other Income/Expense, Net	$1.024M	$0.00	$613.0K
YoY Change	67.05%	-100.0%
Pretax Income	-$1.621M	$4.780M	-$2.090M
YoY Change	-22.44%	-125.39%	-31.48%
Income Tax	-$226.0K	$1.630M	-$693.0K
% Of Pretax Income		34.1%
Net Earnings	$3.935M	$5.114M	-$935.0K
YoY Change	-520.86%	-145.42%	-47.18%
Net Earnings / Revenue	12.95%	19.2%	-2.98%
Basic Earnings Per Share	$0.42	$0.54	-$0.10
Diluted Earnings Per Share	$0.42	$0.54	-$0.10
COMMON SHARES
Basic Shares Outstanding	9.446M shares	9.448M shares	9.448M shares
Diluted Shares Outstanding	9.446M shares	9.448M shares	9.448M shares

Balance Sheet

Concept	2012 Q4	2012 Q2	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.500M	$2.100M	$500.0K
YoY Change	1600.0%	-71.23%	-58.33%
Cash & Equivalents	$7.733M	$2.057M	$500.0K
Short-Term Investments
Other Short-Term Assets	$10.60M	$11.20M	$10.10M
YoY Change	4.95%	-19.42%	5.21%
Inventory	$3.922M	$3.884M	$4.300M
Prepaid Expenses
Receivables	$14.23M	$13.23M	$16.10M
Other Receivables	$700.0K	$200.0K	$2.100M
Total Short-Term Assets	$37.86M	$30.62M	$33.20M
YoY Change	14.03%	-29.45%	-7.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$30.39M	$30.08M	$31.90M
YoY Change	-4.74%	-10.74%	-19.24%
Goodwill	$461.0K	$461.0K
YoY Change
Intangibles	$3.248M	$3.320M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.735M	$894.0K	$11.00M
YoY Change	-84.23%	-90.97%	2650.0%
Total Long-Term Assets	$39.85M	$48.55M	$47.70M
YoY Change	-16.46%	0.32%	-21.03%
TOTAL ASSETS
Total Short-Term Assets	$37.86M	$30.62M	$33.20M
Total Long-Term Assets	$39.85M	$48.55M	$47.70M
Total Assets	$77.70M	$79.17M	$80.90M
YoY Change	-3.95%	-13.76%	-16.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.402M	$6.934M	$7.900M
YoY Change	6.35%	-7.55%	-9.2%
Accrued Expenses	$6.900M	$7.200M	$7.400M
YoY Change	-6.76%	-8.86%	-17.78%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$5.931M	$6.700M
YoY Change	-100.0%	11.91%	139.29%
Long-Term Debt Due	$9.488M	$9.350M	$2.100M
YoY Change	351.81%	345.24%	-93.07%
Total Short-Term Liabilities	$33.37M	$31.81M	$32.60M
YoY Change	2.37%	1.64%	-35.7%
LONG-TERM LIABILITIES
Long-Term Debt	$6.435M	$13.74M	$20.90M
YoY Change	-69.21%	-53.58%	895.24%
Other Long-Term Liabilities	$724.0K	$907.0K	$4.700M
YoY Change	-84.6%	-81.1%	17.5%
Total Long-Term Liabilities	$12.49M	$18.07M	$25.60M
YoY Change	-51.23%	-47.48%	319.67%
TOTAL LIABILITIES
Total Short-Term Liabilities	$33.37M	$31.81M	$32.60M
Total Long-Term Liabilities	$12.49M	$18.07M	$25.60M
Total Liabilities	$45.86M	$49.88M	$58.20M
YoY Change	-21.21%	-24.19%	-1.19%
SHAREHOLDERS EQUITY
Retained Earnings	$14.05M	$11.54M
YoY Change
Common Stock	$4.725M	$4.724M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.80M	$29.30M	$22.60M
YoY Change
Total Liabilities & Shareholders Equity	$77.70M	$79.17M	$80.90M
YoY Change	-3.95%	-13.76%	-16.08%

Cashflow Statement

Concept	2012 Q4	2012 Q2	2011 Q4
OPERATING ACTIVITIES
Net Income	$3.935M	$5.114M	-$935.0K
YoY Change	-520.86%	-145.42%	-47.18%
Depreciation, Depletion And Amortization	$989.0K	$1.020M	$1.120M
YoY Change	-11.7%	-3.77%	-21.13%
Cash From Operating Activities	$2.710M	$3.740M	$330.0K
YoY Change	721.21%	-48.63%	-113.69%
INVESTING ACTIVITIES
Capital Expenditures	$417.0K	-$900.0K	-$180.0K
YoY Change	-331.67%	233.33%	-10.0%
Acquisitions
YoY Change
Other Investing Activities	$8.310M	-$380.0K	-$70.00K
YoY Change	-11971.43%	46.15%	133.33%
Cash From Investing Activities	$7.880M	-$1.270M	-$250.0K
YoY Change	-3252.0%	139.62%	4.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.370M	-1.280M	30.00K
YoY Change	-11333.33%	412.0%	-97.0%
NET CHANGE
Cash From Operating Activities	2.710M	3.740M	330.0K
Cash From Investing Activities	7.880M	-1.270M	-250.0K
Cash From Financing Activities	-3.370M	-1.280M	30.00K
Net Change In Cash	7.220M	1.190M	110.0K
YoY Change	6463.64%	-81.69%	-106.67%
FREE CASH FLOW
Cash From Operating Activities	$2.710M	$3.740M	$330.0K
Capital Expenditures	$417.0K	-$900.0K	-$180.0K
Free Cash Flow	$2.293M	$4.640M	$510.0K
YoY Change	349.61%	-38.54%	-123.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	ssy	Cash And Cash Equivalent At Carrying Value CashAndCashEquivalentAtCarryingValue	519000
CY2012Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10198000
CY2012Q4	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	4016000
CY2012Q4	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2012Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	31847000
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9446039	shares
CY2012Q4	us-gaap	Business Acquisition Purchase Price Allocation Assets Acquired BusinessAcquisitionPurchasePriceAllocationAssetsAcquired	1500000
CY2007Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	24.74	acre
CY2011Q4	us-gaap	Segment Reporting Information Net Assets SegmentReportingInformationNetAssets	80850000
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4391000
CY2012Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	17000
CY2012Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-497000
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	33372000
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	3870000
CY2012Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	15924000
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	5257000
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	14054000
CY2012Q4	us-gaap	Assets Assets	77704000
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7733000
CY2012Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	24673000
CY2012Q4	us-gaap	Escrow Deposit EscrowDeposit	753000
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14227000
CY2012Q4	us-gaap	Inventory Net InventoryNet	3922000
CY2012Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	862000
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	10446000
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	62732000
CY2012Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	10721000
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1735000
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	77704000
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9446000	shares
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	4725000
CY2012Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	2165000
CY2012Q4	us-gaap	Goodwill Goodwill	461000
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2507000
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0
CY2012Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	9460000
CY2012Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	12485000
CY2012Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	70000
CY2012Q4	us-gaap	Long Term Debt LongTermDebt	0
CY2012Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	134000
CY2012Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3248000
CY2012Q4	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	6705000
CY2012Q4	us-gaap	Subordinated Debt Current SubordinatedDebtCurrent	300000
CY2012Q4	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	483
CY2012Q4	us-gaap	Segment Reporting Information Net Assets SegmentReportingInformationNetAssets	77634000
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30387000
CY2012Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	9488000
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9446000	shares
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	14227000
CY2012Q4	us-gaap	Assets Current AssetsCurrent	37857000
CY2012Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13565000
CY2012Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	0
CY2012Q4	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	2002000
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	32345000
CY2012Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	6435000
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	724000
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	8402000
CY2012Q4	ssy	Net Operating Loss Carry Forwards NetOperatingLossCarryForwards	2418000
CY2012Q4	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	3324000
CY2012Q4	ssy	Cash And Cash Equivalent At Carrying Value CashAndCashEquivalentAtCarryingValue	7733000
CY2012Q4	ssy	Net Current Assets Of Subsidiary NetCurrentAssetsOfSubsidiary	0
CY2012Q4	ssy	Net Noncurrent Assets Of Subsidiary NetNoncurrentAssetsOfSubsidiary	0
CY2012Q4	ssy	Incentive Reimbursement Assets Current IncentiveReimbursementAssetsCurrent	577000
CY2012Q4	ssy	Accumulated Amortization Of Finance Costs AccumulatedAmortizationOfFinanceCosts	2710000
CY2012Q4	ssy	Amount Of Installment AmountOfInstallment	150000
CY2012Q4	ssy	Current Maturities Subordinated Long Term Debt CurrentMaturitiesSubordinatedLongTermDebt	300000
CY2010Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	71000
CY2011Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	37000
CY2011Q2	ssy	Cash And Cash Equivalent At Carrying Value CashAndCashEquivalentAtCarryingValue	7250000
CY2011Q3	us-gaap	Share Price SharePrice	1.90
CY2011Q3	ssy	Pre Payment On Credit Facility Term Loan PrePaymentOnCreditFacilityTermLoan	8000000
CY2012Q2	us-gaap	Deferred Income Taxes And Other Assets Noncurrent DeferredIncomeTaxesAndOtherAssetsNoncurrent	5891000
CY2012Q2	us-gaap	Preferred Stock Share Subscriptions PreferredStockShareSubscriptions	2000000	shares
CY2012Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	29291000
CY2012Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4584000
CY2012Q2	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	29000
CY2012Q2	us-gaap	Common Stock No Par Value CommonStockNoParValue
CY2012Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2012Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-497000
CY2012Q2	us-gaap	Liabilities Current LiabilitiesCurrent	31814000
CY2012Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4231000
CY2012Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	20638000
CY2012Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	0
CY2012Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	11543000
CY2012Q2	us-gaap	Assets Assets	79172000
CY2012Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2057000
CY2012Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	22349000
CY2012Q2	us-gaap	Escrow Deposit EscrowDeposit	0
CY2012Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	13228000
CY2012Q2	us-gaap	Inventory Net InventoryNet	3884000
CY2012Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	0
CY2012Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9121000
CY2012Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	63856000
CY2012Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	894000
CY2012Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	79172000
CY2012Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9447000	shares
CY2012Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	229000
CY2012Q2	us-gaap	Common Stock Value CommonStockValue	4724000
CY2012Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	0
CY2012Q2	us-gaap	Goodwill Goodwill	461000
CY2012Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2566000
CY2012Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	2449000
CY2012Q2	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	18472000
CY2012Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	18067000
CY2012Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	198000
CY2012Q2	us-gaap	Long Term Debt LongTermDebt	16086000
CY2012Q2	us-gaap	Capital Lease Obligations CapitalLeaseObligations	176000
CY2012Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3320000
CY2012Q2	us-gaap	Deferred Tax Assets Net Current DeferredTaxAssetsNetCurrent	5174000
CY2012Q2	us-gaap	Subordinated Debt Current SubordinatedDebtCurrent	300000
CY2012Q2	us-gaap	Due To Other Related Parties Current And Noncurrent DueToOtherRelatedPartiesCurrentAndNoncurrent	644
CY2012Q2	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2012Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	30082000
CY2012Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	9050000
CY2012Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2012Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9447000	shares
CY2012Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	13228000
CY2012Q2	us-gaap	Assets Current AssetsCurrent	30618000
CY2012Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	13521000
CY2012Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	5931000
CY2012Q2	us-gaap	Subordinated Long Term Debt SubordinatedLongTermDebt	2152000
CY2012Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	33774000
CY2012Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11588000
CY2012Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	907000
CY2012Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	6934000
CY2012Q2	ssy	Professional Liability Risks Non Current ProfessionalLiabilityRisksNonCurrent	3191000
CY2012Q2	ssy	Cash And Cash Equivalent At Carrying Value CashAndCashEquivalentAtCarryingValue	2057000
CY2012Q2	ssy	Net Current Assets Of Subsidiary NetCurrentAssetsOfSubsidiary	1846000
CY2012Q2	ssy	Net Noncurrent Assets Of Subsidiary NetNoncurrentAssetsOfSubsidiary	7906000
CY2012Q2	ssy	Incentive Reimbursement Assets Current IncentiveReimbursementAssetsCurrent	0
CY2012Q2	ssy	Accumulated Amortization Of Finance Costs AccumulatedAmortizationOfFinanceCosts	2523000
CY2012Q2	ssy	Current Maturities Subordinated Long Term Debt CurrentMaturitiesSubordinatedLongTermDebt	300000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2219000
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	1400000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	8935000
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.07
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2345000
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-518000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	2000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9253000	shares
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.07
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	650000
	us-gaap	Interest Paid InterestPaid	2371000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	309000
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6731000
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	372000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2568000
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	1059000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.27
	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	2219000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	12741000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	8111000
	us-gaap	Net Income Loss NetIncomeLoss	-2490000
	us-gaap	Other Expenses OtherExpenses	1272000
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3140000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.27
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	396000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9253000	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5190000
	us-gaap	Cost Of Services CostOfServices	3923000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2490000
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	17272000
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1388000
	us-gaap	Supplies Expense SuppliesExpense	4260000
	us-gaap	Revenues Revenues	60957000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1760000
	us-gaap	Sales Revenue Net SalesRevenueNet	55202000
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	358
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	20000
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.34
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	85000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-27000
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	413000
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	28000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	34000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4900000
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1127000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	26352000
	us-gaap	Interest Expense InterestExpense	2334000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	257000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1023000
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	36000
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.34
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	84000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0
	ssy	Discontinued Operation Income Tax Expense Benefit DiscontinuedOperationIncomeTaxExpenseBenefit	409000
	ssy	Defined Benefit Plan Net Periodic Benefit Costs DefinedBenefitPlanNetPeriodicBenefitCosts	44000
	ssy	Noncash Assets Acquired Under Capital Lease Obligation Continuing Operations NoncashAssetsAcquiredUnderCapitalLeaseObligationContinuingOperations	80000
	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	413000
	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	105000
	ssy	Provision For Doubtful Accounts And Sales Return ProvisionForDoubtfulAccountsAndSalesReturn	5755000
	ssy	Expenses On Physician Guarantees And Recruitment ExpensesOnPhysicianGuaranteesAndRecruitment	282000
	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	316000
	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	51000
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0000096793
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Trading Symbol TradingSymbol	SSY
	dei	Entity Registrant Name EntityRegistrantName	SUNLINK HEALTH SYSTEMS INC
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1973000
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-5931000
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	17007000
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.59
	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	9553000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16351000
	us-gaap	Investment Income Interest InvestmentIncomeInterest	0
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
	us-gaap	Allowance For Doubtful Accounts Receivable Charge Offs AllowanceForDoubtfulAccountsReceivableChargeOffs	4949000
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.59
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5528000
	us-gaap	Interest Paid InterestPaid	1208000
	us-gaap	Line Of Credit Facility Initiation Date1 LineOfCreditFacilityInitiationDate1	2008-04-23
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5676000
	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	288000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3465000
	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	573000
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
	us-gaap	Nature Of Operations NatureOfOperations	<div> <p style="MARGIN-TOP: 18px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><b>Note 2. – Business Operations</b></font></p> <!-- xbrl,body --> <p style="MARGIN-TOP: 6px; MARGIN-BOTTOM: 0px"><font style="FONT-FAMILY: Times New Roman" size="2"><u>Business Operations</u></font></p> <p style="MARGIN-TOP: 6px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">SunLink Health Systems, Inc. subsidiaries provide healthcare services in certain rural and exurban markets in the United States. SunLink’s business is composed of the ownership of subsidiaries which operate two business segments:</font></p> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Healthcare Facilities, which consist of</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our four community hospitals which have a total of 232 licensed beds;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Our two nursing homes, which have a total of 166 licensed beds, each of which is located adjacent to a corresponding SunLink community hospital; and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">One hospital facility and related equipment leased to a third party hospital operator. A third party has an option, through March 15, 2013, to buy the hospital facility and equipment.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="5%"><font size="1"> </font></td> <td valign="top" width="2%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Specialty Pharmacy, which consists of</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Specialty pharmacy services;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Durable medical equipment;</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Institutional pharmacy services; and</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px; FONT-SIZE: 6px">  </p> <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%"> <tr> <td width="9%"><font size="1"> </font></td> <td valign="top" width="3%" align="left"><font style="FONT-FAMILY: Times New Roman" size="2">•</font></td> <td valign="top" width="1%"><font size="1"> </font></td> <td valign="top" align="left"> <p align="left"><font style="FONT-FAMILY: Times New Roman" size="2">Retail pharmacy products and services, all of which are conducted in rural markets.</font></p> </td> </tr> </table> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">SunLink subsidiaries have conducted the healthcare facilities business since 2001 and the specialty pharmacy business since April 2008. The Specialty Pharmacy Segment currently is operated through Carmichael’s Cashway Pharmacy, Inc. (“Carmichael”), a subsidiary of SunLink ScriptsRx, LLC subsidiary, and is composed of a specialty pharmacy business acquired in April 2008 with four service lines.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">SunLink’s Board and management have determined to focus the Company’s strategic investments on enhancing the existing hospital portfolio, including the selective disposal of underperforming and non-strategic subsidiaries.</font></p> <p style="MARGIN-TOP: 12px; TEXT-INDENT: 4%; MARGIN-BOTTOM: 0px"> <font style="FONT-FAMILY: Times New Roman" size="2">On February 5, 2013, the Company announced the commencement of a tender offer to purchase all of its common shares held by holders of 99 or fewer shares (“odd lots”) who owned such shares as of the close of business on January 31, 2013 at the price of $1.50 per share in cash (“Odd Lot Tender Offer”). In addition to the $1.50 per share price, the Company is offering each eligible tendering holder a bonus of $100 upon completion of the Odd Lot Tender Offer for the tender of all shares beneficially owned by such holder which are received and not withdrawn prior to the date of expiration of the Odd Lot Tender Offer, currently March 12, 2013. If all odd lot shareholders tender their shares, SunLink estimates the aggregate cost of the Offer would be approximately $199, including an estimated aggregate purchase price for the odd lot shares of approximately $18, estimated aggregate bonus payments of approximately $38 and estimated fees and expenses of approximately $143. The primary purpose of the Offer is to reduce the number of holders of record of the Company’s common shares in order to permit the Company to deregister the common shares with the SEC. The Company’s Board and management each believes that deregistering the Company’s common shares will result in significant cost savings. The Offer represents a mechanism to provide odd lot shareholders, if they so elect, with the opportunity to tender all or a portion of their shares and, thereby, receive a return of capital without the usual costs associated with open market transactions.</font></p> <!-- xbrl,n --></div>
	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	1973000
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	10766000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	8081000
	us-gaap	Net Income Loss NetIncomeLoss	2511000
	us-gaap	Other Expenses OtherExpenses	1024000
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3017000
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	12000
	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	0
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10795000
	us-gaap	Cost Of Services CostOfServices	3852000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2511000
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	9513000
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1366000
	us-gaap	Supplies Expense SuppliesExpense	4700000
	us-gaap	Revenues Revenues	59557000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1654000
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	753000
	us-gaap	Sales Revenue Net SalesRevenueNet	53540000
	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	525
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	789000
	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	20000
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.32
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	70000
	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	6274000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-308000
	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	1135000
	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	54000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	52000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4671000
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1004000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	26607000
	us-gaap	Interest Expense InterestExpense	1206000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	120000
	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	34000
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.32
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	188000
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	12143000
	ssy	Discontinued Operation Income Tax Expense Benefit DiscontinuedOperationIncomeTaxExpenseBenefit	4598000
	ssy	Defined Benefit Plan Net Periodic Benefit Costs DefinedBenefitPlanNetPeriodicBenefitCosts	68000
	ssy	Noncash Assets Acquired Under Capital Lease Obligation Continuing Operations NoncashAssetsAcquiredUnderCapitalLeaseObligationContinuingOperations	0
	ssy	Payments To Acquire Property Plant And Equipment Continuing Operations PaymentsToAcquirePropertyPlantAndEquipmentContinuingOperations	1135000
	ssy	Payments To Acquire Property Plant And Equipment Discontinued Operations PaymentsToAcquirePropertyPlantAndEquipmentDiscontinuedOperations	41000
	ssy	Provision For Doubtful Accounts And Sales Return ProvisionForDoubtfulAccountsAndSalesReturn	6017000
	ssy	Expenses On Physician Guarantees And Recruitment ExpensesOnPhysicianGuaranteesAndRecruitment	51000
	ssy	Assets Acquired Under Capital Lease Obligation Discontinued Operations AssetsAcquiredUnderCapitalLeaseObligationDiscontinuedOperations	0
	ssy	Common Shares Sought To Sell In Private Offering CommonSharesSoughtToSellInPrivateOffering	3800000	shares
	ssy	Loan Proceeds To Be Used To Finance Improvements LoanProceedsToBeUsedToFinanceImprovements	1000000
	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	176000
	ssy	Number Of Physicians Under Guarantee Agreements NumberOfPhysiciansUnderGuaranteeAgreements	1	Physician
CY2011Q3	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	2500000
CY2011Q3	ssy	Share Issued Under Private Placement ShareIssuedUnderPrivatePlacement	1329000	shares
CY2012Q4	ssy	Business Acquisition Date Of Acquiree Purchase Option Agreement BusinessAcquisitionDateOfAcquireePurchaseOptionAgreement	90 days
CY2011	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	34000
CY2012	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	8000
CY2011Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1120000
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.05
CY2011Q4	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0
CY2011Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	0
CY2011Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9448000	shares
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.05
CY2011Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	462000
CY2011Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	39000
CY2011Q4	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	265000
CY2011Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1059000
CY2011Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	753000
CY2011Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2011Q4	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	1120000
CY2011Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	7807000
CY2011Q4	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	4035000
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	-935000
CY2011Q4	us-gaap	Other Expenses OtherExpenses	613000
CY2011Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1397000
CY2011Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2011Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9448000	shares
CY2011Q4	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	51000
CY2012Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	989000
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.56
CY2012Q4	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	8362000
CY2012Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	0
CY2011Q4	us-gaap	Cost Of Services CostOfServices	1858000
CY2011Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-935000
CY2011Q4	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	8601000
CY2011Q4	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	428000
CY2011Q4	us-gaap	Supplies Expense SuppliesExpense	2069000
CY2011Q4	us-gaap	Revenues Revenues	31401000
CY2011Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-693000
CY2011Q4	us-gaap	Sales Revenue Net SalesRevenueNet	29025000
CY2011Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	103
CY2011Q4	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2011Q4	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	10000
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2011Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	42000
CY2011Q4	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	197000
CY2011Q4	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	14000
CY2011Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29000
CY2011Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2090000
CY2011Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	550000
CY2011Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	13219000
CY2011Q4	us-gaap	Interest Expense InterestExpense	1031000
CY2011Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0
CY2011Q4	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	18000
CY2011Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2011Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	42000
CY2011Q4	ssy	Discontinued Operation Income Tax Expense Benefit DiscontinuedOperationIncomeTaxExpenseBenefit	291000
CY2011Q4	ssy	Defined Benefit Plan Net Periodic Benefit Costs DefinedBenefitPlanNetPeriodicBenefitCosts	22000
CY2011Q4	ssy	Provision For Doubtful Accounts And Sales Return ProvisionForDoubtfulAccountsAndSalesReturn	2376000
CY2011Q4	ssy	Expenses On Physician Guarantees And Recruitment ExpensesOnPhysicianGuaranteesAndRecruitment	225000
CY2012Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9446000	shares
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Charge Offs AllowanceForDoubtfulAccountsReceivableChargeOffs	2464000
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.56
CY2012Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	5330000
CY2012Q4	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	177000
CY2012Q4	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	419000
CY2012Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-974000
CY2012Q4	us-gaap	Discontinued Operation Income Loss From Discontinued Operation Before Income Tax DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax	196000
CY2012Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2012Q4	us-gaap	Cost Of Goods Sold Depreciation And Amortization CostOfGoodsSoldDepreciationAndAmortization	989000
CY2012Q4	us-gaap	Interest Expense InterestExpense	647000
CY2012Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0
CY2012Q4	us-gaap	Defined Benefit Plan Interest Cost DefinedBenefitPlanInterestCost	17000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.15
CY2012Q4	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	104000
CY2012Q4	ssy	Discontinued Operation Income Tax Expense Benefit DiscontinuedOperationIncomeTaxExpenseBenefit	3228000
CY2012Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	6529000
CY2012Q4	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	3976000
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	3935000
CY2012Q4	us-gaap	Other Expenses OtherExpenses	1024000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1395000
CY2012Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.42
CY2012Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9446000	shares
CY2012Q4	us-gaap	Cost Of Services CostOfServices	1896000
CY2012Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3935000
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	4684000
CY2012Q4	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	193000
CY2012Q4	us-gaap	Supplies Expense SuppliesExpense	2437000
CY2012Q4	us-gaap	Revenues Revenues	30385000
CY2012Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-226000
CY2012Q4	us-gaap	Sales Revenue Net SalesRevenueNet	27850000
CY2012Q4	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	312
CY2012Q4	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2012Q4	us-gaap	Defined Benefit Plan Expected Return On Plan Assets DefinedBenefitPlanExpectedReturnOnPlanAssets	10000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.15
CY2012Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	35000
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	2712000
CY2012Q4	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	417000
CY2012Q4	us-gaap	Defined Benefit Plan Amortization Of Prior Service Cost Credit DefinedBenefitPlanAmortizationOfPriorServiceCostCredit	27000
CY2012Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	24000
CY2012Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1621000
CY2012Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	458000
CY2012Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	13386000
CY2012Q4	ssy	Defined Benefit Plan Net Periodic Benefit Costs DefinedBenefitPlanNetPeriodicBenefitCosts	34000
CY2012Q4	ssy	Provision For Doubtful Accounts And Sales Return ProvisionForDoubtfulAccountsAndSalesReturn	2535000
CY2012Q4	ssy	Expenses On Physician Guarantees And Recruitment ExpensesOnPhysicianGuaranteesAndRecruitment	20000
CY2012Q4	ssy	Financing Costs And Expenses FinancingCostsAndExpenses	2710000
CY2012Q4	ssy	Net Revenue Related To Settlements And Filings Of Prior Year Reports NetRevenueRelatedToSettlementsAndFilingsOfPriorYearReports	27000

Files In Submission

Name	View Source	Status
0001193125-13-060336-index-headers.html	Edgar Link	pending
0001193125-13-060336-index.html	Edgar Link	pending
0001193125-13-060336.txt	Edgar Link	pending
0001193125-13-060336-xbrl.zip	Edgar Link	pending
d453108d10q.htm	Edgar Link	pending
d453108dex311.htm	Edgar Link	pending
d453108dex312.htm	Edgar Link	pending
d453108dex321.htm	Edgar Link	pending
d453108dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssy-20121231.xml	Edgar Link	completed
ssy-20121231.xsd	Edgar Link	pending
ssy-20121231_cal.xml	Edgar Link	unprocessable
ssy-20121231_def.xml	Edgar Link	unprocessable
ssy-20121231_lab.xml	Edgar Link	unprocessable
ssy-20121231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy

2012 Q4 Form 10-Q Financial Statement

#000119312513060336 Filed on February 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY SUNLINK HEALTH SYSTEMS INC Stock $ssy

2012 Q4 Form 10-Q Financial Statement

#000119312513060336 Filed on February 14, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SSY
SUNLINK HEALTH SYSTEMS INC Stock $ssy